-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...
More »SEARCH RESULT
Total Matching Records found : 251
A crime well reported is half-solved -Rukmini S
-The Hindu The latest data from the National Crime Records Bureau show that it is time to change our understanding of felony and its registration by the police With every passing year of writing on the National Crime Records Bureau (NCRB)’s crime data, it has become increasingly clear that what I am forced to do is essentially compare apples and oranges, and then make a normative call based on that comparison. This...
More »Government to hike health care investment to 2.5% of GDP by 2020 -Nitin Sethi
-Business Standard Health cess recommended; public health care to be primary focus The National Democratic Alliance (NDA) government plans to increase public investment in health from 1.04 per cent of GDP (gross domestic product) to 2.5 per cent by 2020, with 70 per cent of this being dedicated to primary health care. This target has been set in the overhauled draft National Health Policy that now emphasises on substantially ratcheting up government...
More »Medicines for diabetes, infections to cost 40% less -Rupali Mukherjee & Sushmi Dey
-The Times of India MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations. The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate. These drugs and combinations are...
More »Drug pricing policy irrational, re-examine it, Supreme Court tells Centre
-The Times of India NEW DELHI: The Supreme Court on Wednesday asked the Centre to re-examine its drug pricing policy for essential medicines, calling it "unreasonable and irrational" as the price of some medicines is at around 4000% higher than what has been fixed by some state governments. A bench headed by Justice TS Thakur asked the ministry of chemicals and fertilizers to analyze and give explanation why the controlled price of...
More »
